Sanofi Accused Of Shorting Staff For Sales Of Cancer Drug
Two former Sanofi-Aventis US LLC sales employees hit the pharmaceutical giant with a putative class action Tuesday, claiming the company backtracked on commission agreements stemming from sales of the cancer drug...To view the full article, register now.
Already a subscriber? Click here to view full article